Rheumatoid Arthritis Diagnosis Tests

Rheumatoid Arthritis Diagnosis Tests

Global Rheumatoid Arthritis Diagnosis Tests Market to Reach $802.6 Million by 2027

In the changed post COVID-19 business landscape, the global market for Rheumatoid Arthritis Diagnosis Tests estimated at US$579.8 Million in the year 2020, is projected to reach a revised size of US$802.6 Million by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Serology Tests, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$561.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Monitoring Ra Treatment Efficiency Tests segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $119.8 Million, While China is Forecast to Grow at 6.1% CAGR

The Rheumatoid Arthritis Diagnosis Tests market in the U.S. is estimated at US$119.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$120.4 Million by the year 2027 trailing a CAGR of 6.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Select Competitors (Total 65 Featured) -

  • Abbott Diagnostics
  • Augurex Life Sciences Corp.
  • Beckman Coulter, Inc.
  • Bio Rad Laboratories Inc.
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genway Biotech, Inc.
  • Microdrop LLC (imaware)
  • Qiagen NV
  • Siemens Healthcare GmbH
  • Svar Life Science AB
  • Thermo Fisher Scientific Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Rheumatoid Arthritis Diagnosis Tests – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
A Prelude to Rheumatoid Arthritis
Causes and Risk Factors
Symptoms
Rheumatoid Arthritis Diagnostic Tests
Serological Tests
Monitoring RA Treatment Efficiency Tests
Kidney Function Tests
Impact of Covid-19 and a Looming Global Recession
Impact of COVID-19 on Rheumatoid Arthritis Diagnostic Tests
Global Market Outlook and Prospects
Global Rheumatoid Arthritis Diagnostic Tests Market Set to Witness Significant Growth
Select RA Diagnostic Tests by Player
The US and Europe Dominate the Global Market, Developing Countries to Witness Fastest Growth
Competition
Recent Market Activity
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Rheumatoid Arthritis Propels the Demand for Rheumatoid Arthritis Diagnosis
Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
Growing Aging Population to Drive the Demand for RA Diagnostic Tests
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Increasing Use of Rapid Diagnosis Tests Platform
Select List of RA Biomarkers used in Clinical Practice
Investigational Biomarkers to Diagnose and Monitor RA
New Biomarker Tests to Drive the Market Growth
More Specific Biomarker Tests
Growing Demand for Multiple Tests
Repercussions of Sub Optimal Accuracy in RA Testing Drive the Need for Multiple Tests
Recent Advancements in Treatment Methods to Boost Market Growth
Uptrend in Healthcare Expenditure Drives Opportunities
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
Increasing Obesity Levels Underpins Market Growth
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Technological Advancements Widen the Capabilities of RA Arthritis Tests
A Few of the Recent Launches and Advancements
Rapid RA Diagnostic Tests for Obtaining Results in Minutes
imaware™ Introduces At-Home Rheumatoid Arthritis Screening Test
Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test
Scipher Medicine® Ties Up with Ambry Genetics® to Bring Precision Medicine Test for Rheumatoid Arthritis to Market
A New Blood Test Could to Predict Rheumatoid Arthritis
A New Blood Test Could to Predict Rheumatoid Arthritis
IPM Launches Innovative Program for Rheumatoid Arthritis
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Serology Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Monitoring RA Treatment Efficiency Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Monitoring RA Treatment Efficiency Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Monitoring RA Treatment Efficiency Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 19: USA Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 20: USA Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: USA 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 22: USA Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 23: USA Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: USA 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
CANADA
TABLE 25: Canada Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: Canada Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: Canada 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 28: Canada Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: Canada Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: Canada 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
JAPAN
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 31: Japan Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: Japan Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: Japan 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 34: Japan Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: Japan Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: Japan 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
CHINA
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 37: China Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: China Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: China 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 40: China Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: China Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: China 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
EUROPE
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 43: Europe Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 46: Europe Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
TABLE 49: Europe Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 50: Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
FRANCE
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 52: France Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: France Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: France 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 55: France Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: France Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: France 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
GERMANY
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 58: Germany Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: Germany Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: Germany 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 61: Germany Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: Germany Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: Germany 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
ITALY
TABLE 64: Italy Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Italy Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Italy 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 67: Italy Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Italy Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Italy 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
UNITED KINGDOM
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 70: UK Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: UK Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: UK 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 73: UK Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: UK Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: UK 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
SPAIN
TABLE 76: Spain Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: Spain Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: Spain 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 79: Spain Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: Spain Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: Spain 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
RUSSIA
TABLE 82: Russia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Russia Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Russia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 85: Russia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Russia Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Russia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Rest of Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Rest of Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 91: Rest of Europe Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Rest of Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Rest of Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 97: Asia-Pacific Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 101: Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
AUSTRALIA
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 103: Australia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: Australia Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: Australia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 106: Australia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: Australia Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: Australia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
INDIA
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
TABLE 109: India Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: India Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: India 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 112: India Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: India Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: India 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 115: South Korea Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: South Korea Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: South Korea 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 118: South Korea Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: South Korea Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: South Korea 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 121: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Rest of Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: Rest of Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Rest of Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: Rest of Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
LATIN AMERICA
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 127: Latin America Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 130: Latin America Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
TABLE 133: Latin America Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 134: Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
ARGENTINA
TABLE 136: Argentina Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: Argentina Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: Argentina 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 139: Argentina Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: Argentina Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: Argentina 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
BRAZIL
TABLE 142: Brazil Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Brazil Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: Brazil 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 145: Brazil Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Brazil Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: Brazil 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
MEXICO
TABLE 148: Mexico Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Mexico Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Mexico 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 151: Mexico Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Mexico Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Mexico 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 154: Rest of Latin America Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Rest of Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Rest of Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 157: Rest of Latin America Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Rest of Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: Rest of Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
MIDDLE EAST
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 160: Middle East Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 163: Middle East Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
TABLE 166: Middle East Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 167: Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
IRAN
TABLE 169: Iran Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: Iran Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: Iran 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 172: Iran Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: Iran Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: Iran 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
ISRAEL
TABLE 175: Israel Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: Israel Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: Israel 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 178: Israel Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Israel Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Israel 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 181: Saudi Arabia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Saudi Arabia Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Saudi Arabia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Saudi Arabia Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Saudi Arabia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 187: UAE Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 188: UAE Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: UAE 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 190: UAE Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: UAE Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: UAE 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 193: Rest of Middle East Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: Rest of Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: Rest of Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: Rest of Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: Rest of Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
AFRICA
Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 199: Africa Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Africa Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: Africa 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
TABLE 202: Africa Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Africa Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 204: Africa 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 65

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings